FDA grants CLIA-waived Status to CoaguChek XS Plus System for PT/INR Testing
Roche Diagnostics announced that the FDA has granted CLIA-waived status to the CoaguChek XS Plus system, a point-of-care anticoagulation monitor that offers connectivity and data management tools to help healthcare professionals manage PT/INR (blood clotting time) testing.
Read More